Deal alert: Graft Polymer (UK) Plc
PKF supports admisson to the Main Market of the London Stock Exchange
PKF has supported Graft Polymer (UK) Plc on its admission to the Main Market of the London Stock Exchange.
Based on the placing price of 21.5p, Graft Polymer has raised gross proceeds of £5 million, giving a market capitalisation of £22.4 million on admission. Following admission, the company will have approximately104 million Ordinary Shares in issue.
Established in 2017 by a group of polymer technology experts and venture capitalists, Graft Polymer’s core business comprises polymer modification and development of drug delivery systems. The fundraising of £5 million is to fund accelerated growth, expand the group’s research and production facility in Slovenia to meet rising customer demand, upgrade existing facilities to enable future IP registration, and increase both inventory and marketing opportunities following expected increased sales.
PKF acted as reporting accountant on the transaction and the Capital Markets team included Adam Humphreys and Lauren Haslam.
“PKF’s expertise and unwavering support were important factors in enabling us to complete LSE Main Market admission.”
Yifat Steuer, CFO and Executive Director | Graft Polymer (UK) Plc
Find out more about how our Capital Markets team can support you and your business here.